1887
  1. Home
  2. Eurosurveillance
  3. Volume 26, Issue 42, 21/Oct/2021
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

We monitored trends of severe COVID-19 morbidity in Slovenia during weeks 13 to 37 2021. National weekly rates of severe acute respiratory infections (SARI) cases testing positive for SARS-CoV-2 at admission in all hospitals varied between 0.2 and 16.3 cases per 100,000 population. Of those without previous COVID-19 diagnosis, SARI COVID-19 admission rates ranged between 0.3 and 17.5 per 100,000 unvaccinated, and 0.0 and 7.3 per 100,000 fully vaccinated individuals. National SARI COVID-19 surveillance is essential in informing COVID-19 response.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.42.2100937
2021-10-21
2024-12-22
/content/10.2807/1560-7917.ES.2021.26.42.2100937
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/42/eurosurv-26-42-1.html?itemId=/content/10.2807/1560-7917.ES.2021.26.42.2100937&mimeType=html&fmt=ahah

References

  1. Državni zbor Republike Slovenije. Zakon o dodatnih ukrepih za omilitev posledic COVID-19. [Law on additional interventions for diminishing COVID-19 impact]. Ljubljana: Uradni list Republike Slovenije, d. o. o. [Accessed: 9 Sep 2021]. Slovenian. Available from: https://www.uradni-list.si/glasilo-uradni-list-rs/vsebina?urlurid=2021315
  2. European Centre for Disease Prevention and Control (ECDC). Case definition for coronavirus disease 2019 (COVID-19), as of 3 December 2020. Stockholm: ECDC. [Accessed: 27 Aug 2021]. Available from: https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition
  3. European Centre for Disease Prevention and Control (ECDC). Surveillance definitions for COVID-19. Stockholm: ECDC. [Accessed: 27 Aug 2021]. Available from: https://www.ecdc.europa.eu/en/covid-19/surveillance/surveillance-definitions
  4. Državni zbor Republike Slovenije. Zakon o zbirkah podatkov s področja zdravstvenega varstva. [Law on datasets in health care]. Ljubljana: Uradni list Republike Slovenije, d. o. o. [Accessed: 27 Aug 2021]. Slovenian. Available from: http://www.uradni-list.si/1/content?id=26736
  5. Nacionalni inštitut za javno zdravje (NIJZ). Elektronski register cepljenih oseb in neželenih učinkov po cepljenju. [Electronic Registry of vaccinated individuals and adverse events following vaccinations]. Ljubljana: NIJZ. [Accessed: 9 Sep 2021]. Slovenian. Available from: https://www.nijz.si/sl/elektronski-register-cepljenih-oseb-in-nezelenih-ucinkov-po-cepljenju-erco
  6. European Centre for Disease Prevention and Control (ECDC). Strategies for the surveillance of COVID-19. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-surveillance-strategy-9-Apr-2020.pdf
  7. World Health Organization (WHO). Maintaining surveillance of influenza and monitoring SARS-CoV-2 – adapting Global Influenza surveillance and Response System (GISRS) and sentinel systems during the COVID-19 pandemic: Interim guidance. Geneva: WHO; 2020. Available from: https://www.who.int/publications/i/item/maintaining-surveillance-of-influenza-and-monitoring-sars-cov-2-adapting-global-influenza-surveillance-and-response-system-(gisrs)-and-sentinel-systems-during-the-covid-19-pandemic
  8. European Centre for Disease Prevention and Control (ECDC). COVID-19 country overviews. Week 34, 2021. Stockholm: ECDC. [Accessed: 9 Sept 2021]. Available from: https://covid19-country-overviews.ecdc.europa.eu
  9. European Centre for Disease Prevention and Control (ECDC). TESSy - The European Surveillance System. Coronavirus disease 2019 (COVID-19) data Reporting Protocol Version 5.1, 26 July 2021. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-Reporting-Protocol-v5.1.pdf
  10. Nacionalni inštitut za javno zdravje (NIJZ). Cepljenje proti COVID-19 v Sloveniji. [Vaccination against COVID-19 in Slovenia]. Ljubljana: NIJZ. [Accessed: 10 Sept 2021]. Slovenian. Available from: https://app.powerbi.com/view?r=eyJrIjoiYWQ3NGE1NTMtZWJkMi00NzZmLWFiNDItZDc5YjU5MGRkOGMyIiwidCI6ImFkMjQ1ZGFlLTQ0YTAtNGQ5NC04OTY3LTVjNjk5MGFmYTQ2MyIsImMiOjl9
  11. European Centre for Disease Prevention and Control (ECDC). SARS-CoV-2 variants of concern. Stockholm: ECDC. [Accessed: 9 Sept 2021]. Available from: https://www.ecdc.europa.eu/en/covid-19/variants-concern
  12. World Health Organization (WHO). Evaluation of COVID-19 vaccine effectiveness: Interim guidance. Geneva: WHO; 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1
  13. Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819-29.  https://doi.org/10.1016/S0140-6736(21)00947-8  PMID: 33964222 
  14. European Centre for Disease Prevention and Control (ECDC). Interim public health considerations for the provision of additional COVID-19 vaccine doses. Stockholm: ECDC. [Accessed: 2 Sep 2021]. Available from: https://www.ecdc.europa.eu/en/publications-data/covid-19-public-health-considerations-additional-vaccine-doses
Enhanced national surveillance of severe acute respiratory infections (SARI) within COVID-19 surveillance, Slovenia, weeks 13 to 37 2021
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Irena+Klavs&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Klavs Irena</a>, <a href="/search?value1=Mojca+Serdt&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Serdt Mojca</a>, <a href="/search?value1=Veronika+U%C4%8Dakar&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Učakar Veronika</a>, <a href="/search?value1=Marta+Grgi%C4%8D-Vitek&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Grgič-Vitek Marta</a>, <a href="/search?value1=Mario+Fafangel&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Fafangel Mario</a>, <a href="/search?value1=Maja+Mrzel&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mrzel Maja</a>, <a href="/search?value1=Lina+Berlot&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Berlot Lina</a>, <a href="/search?value1=Uro%C5%A1+Glavan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Glavan Uroš</a>, <a href="/search?value1=Marjana+Vrh&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vrh Marjana</a>, <a href="/search?value1=Tanja+Kustec&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kustec Tanja</a>, <a href="/search?value1=Miha+Simoniti&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Simoniti Miha</a>, <a href="/search?value1=Bo%C5%BEena+Kotnik+Kevorkijan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kotnik Kevorkijan Božena</a>, <a href="/search?value1=Tatjana+Lejko+Zupanc&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lejko Zupanc Tatjana</a>, <a href="/search?value1=the+EPISARI+Network&option1=author&noRedirect=true" class="nonDisambigAuthorLink">the EPISARI Network</a></span>. Enhanced national surveillance of severe acute respiratory infections (SARI) within COVID-19 surveillance, Slovenia, weeks 13 to 37 2021. <a href="/content/ecdc">Euro Surveill.</a> 2021;26(42):pii=2100937. <a href="https://doi.org/10.2807/1560-7917.ES.2021.26.42.2100937" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2021.26.42.2100937</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 24 Sept 2021;&nbsp;&nbsp; <span class="generated">Accepted</span>: 21 Oct 2021 </span> </p>
/content/10.2807/1560-7917.ES.2021.26.42.2100937
/content/10.2807/1560-7917.ES.2021.26.42.2100937
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error